Verition Fund Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-148,367
| Closed | -$2.86M | – | 3931 |
|
|
2025
Q3 | $2.86M | Buy |
148,367
+58,479
| +65% | +$1.04M | 0.02% | 1678 |
|
|
2025
Q2 | $1.54M | Buy |
89,888
+16,148
| +22% | +$689K | 0.01% | 2149 |
|
|
2025
Q1 | $4.71M | Buy |
73,740
+68,424
| +1,287% | +$7.2M | 0.03% | 882 |
|
|
2024
Q4 | $646K | Buy |
5,316
+1,830
| +52% | +$224K | ﹤0.01% | 2325 |
|
|
2024
Q3 | $435K | Sell |
3,486
-8,475
| -71% | -$1.17M | ﹤0.01% | 2406 |
|
|
2024
Q2 | $1.89M | Buy |
11,961
+6,531
| +120% | +$839K | 0.01% | 1303 |
|
|
2024
Q1 | $703K | Buy |
5,430
+1,896
| +54% | +$232K | 0.01% | 1818 |
|
|
2023
Q4 | $341K | Buy |
3,534
+698
| +25% | +$67K | ﹤0.01% | 1731 |
|
|
2023
Q3 | $344K | Sell |
2,836
-36,200
| -93% | -$4.09M | ﹤0.01% | 1647 |
|
|
2023
Q2 | $4.47M | Buy |
39,036
+32,976
| +544% | +$4.25M | 0.07% | 398 |
|
|
2023
Q1 | $835K | Sell |
6,060
-1,543
| -20% | -$200K | 0.01% | 1022 |
|
|
2022
Q4 | $985K | Buy |
7,603
+3,346
| +79% | +$388K | 0.02% | 920 |
|
|
2022
Q3 | $471K | Buy |
+4,257
| New | +$429K | 0.01% | 1937 |
|
|
2021
Q3 | – | Sell |
-4,565
| Closed | -$355K | – | 2319 |
|
|
2021
Q2 | $355K | Sell |
4,565
-7
| -0.2% | -$531 | 0.01% | 1262 |
|
|
2021
Q1 | $341K | Buy |
+4,572
| New | +$422K | 0.01% | 1049 |
|
|
2020
Q4 | – | Sell |
-3,476
| Closed | -$515K | – | 1390 |
|
|
2020
Q3 | $488K | Buy |
+3,476
| New | +$528K | 0.02% | 591 |
|
|
2020
Q1 | – | Sell |
-5,779
| Closed | -$746K | – | 1041 |
|
|
2019
Q4 | $746K | Buy |
+5,779
| New | +$583K | 0.02% | 535 |
|
|
2019
Q2 | – | Sell |
-7,482
| Closed | -$892K | – | 1361 |
|
|
2019
Q1 | $892K | Buy |
+7,482
| New | +$962K | 0.05% | 439 |
|
|
2018
Q4 | – | Sell |
-6,646
| Closed | -$1.07M | – | 1229 |
|
|
2018
Q3 | $1.07M | Buy |
6,646
+3,506
| +112% | +$479K | 0.05% | 538 |
|
|
2018
Q2 | $415K | Buy |
+3,140
| New | +$296K | 0.03% | 757 |
|
Other funds holding SRPT
EAM
